Article
GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1…
Diabetes, Metabolic Syndrome and Obesity · 2023 · Xiang J, Qin L, Zhong J, Xia N, Liang Y
Key facts
| Title | GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway |
|---|---|
| First author | Xiang J, Qin L, Zhong J, Xia N, Liang Y |
| Journal | Diabetes, Metabolic Syndrome and Obesity |
| Published | Aug 15, 2023 |
| DOI | 10.2147/DMSO.S425642 |
| Devices mentioned | K162583 |
| Product codes mentioned | IYN |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1